The second regulatory shoe has finally dropped for AbbVie, Pfizer and Eli Lilly amid the safety review of JAK inhibitors for ...
Merck & Co. signed a deal under which molnupiravir production will be conducted at Thermo Fisher Scientific’s Ontario, Canada ...
Gilead is recalling two lots of the COVID-19 antiviral Veklury, also known as remdesivir, after a customer complaint flagged ...
Singapore has attracted a slate of pharma heavyweights in recent years. Now, a Merck and Welcome Trust joint venture is ...
As AbbVie's best-selling drug Humira inches toward a 2023 patent cliff, the company has pinned its growth hopes on its ...
On Thursday, the House Committee on Oversight and Reform will hold a hearing to present its findings on an investigation of ...
AstraZeneca recently bundled its COVID-19 vaccine and antibody treatment into a separate division. But there’s a chance that ...
Health inequity has been a major problem for a long time, but COVID-19 brought this reality to the forefront. So, to try to ...
How the mighty have fallen. Regeneron and Sanofi's IL-4/13 immunology drug, Dupixent, has reigned the monthly top ad-spender ...
Learn more about the ways in which AmerisourceBergen has addressed the growing disparities in healthcare which were magnified ...
A U.S. appeals court has declined to resurrect a key patent on Biogen’s once-stalwart multiple sclerosis med Tecfidera, ...
As the world assesses the threat posed by the COVID-19 omicron variant, two top companies producing pandemic drugs and ...